In addition to the immense personal burden, costs associated with treating type 2 diabetes and its complications put immense pressure on public health systems. Because environmental factors play a very significant part in a person’s likelihood of being struck down with the disease, the solution will have to go beyond pharamcological interventions. Prevention will be key. While most of IMI’s research projects so far have concentrated on the mechanisms and pathways of the disease, identifying subtypes, biomarkers and new animal and cellular models, we are also starting to look at it from angles related to behaviour, nutrition, exercise and even psychology. We are also funding projects that will advance our understanding of type 1 diabetes.
In the fight against the diabetes epidemic, new medicines are only half the battle
The diabetes epidemic requires a rethink about obesity
The constant threat of 'hypos' takes a heavy toll on people with diabetes
INNODIA set to speed up clinical trials for type 1 diabetes drugs
Spot it, slow it, and stop it: trials of potential diabetes drugs to get underway